Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial
- Resource Type
- Article
- Source
- In
Contemporary Clinical Trials June 2024 141 - Subject
- Language
- ISSN
- 1551-7144